These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15765433)

  • 1. Endoscopic ulcers with low-dose aspirin and reality testing.
    Graham DY; Chan FK
    Gastroenterology; 2005 Mar; 128(3):807; author reply 807--8. PubMed ID: 15765433
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endoscopic findings of low-dose aspirin associated ulcers].
    Miyake K; Kusunoki M; Sakamoto C
    Nihon Rinsho; 2010 Nov; 68(11):2031-5. PubMed ID: 21061528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of gastroduodenal ulcer in Japanese patients taking low-dose aspirin.
    Iwamoto J; Mizokami Y; Shimokobe K; Ito M; Hirayama T; Saito Y; Ikegami T; Honda A; Matsuzaki Y
    Dig Dis Sci; 2010 Aug; 55(8):2270-4. PubMed ID: 19936921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New guideline for peptic ulcer treatment, attention to low-dose aspirin].
    Yoshino J; Kosaka T
    Nihon Rinsho; 2010 Nov; 68(11):1987-92. PubMed ID: 21061521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.
    Liu CP; Chen WC; Lai KH; Mar GY; Lin SY; Ger LP; Hsu PI;
    Am J Gastroenterol; 2012 Jul; 107(7):1022-9. PubMed ID: 22508148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
    Yeomans N; Lanas A; Labenz J; van Zanten SV; van Rensburg C; Rácz I; Tchernev K; Karamanolis D; Roda E; Hawkey C; Nauclér E; Svedberg LE
    Am J Gastroenterol; 2008 Oct; 103(10):2465-73. PubMed ID: 18637091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial.
    Sung JJ; Lau JY; Ching JY; Wu JC; Lee YT; Chiu PW; Leung VK; Wong VW; Chan FK
    Ann Intern Med; 2010 Jan; 152(1):1-9. PubMed ID: 19949136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptic ulcerations are related to systemic rather than local effects of low-dose aspirin.
    van Oijen MG; Dieleman JP; Laheij RJ; Sturkenboom MC; Jansen JB; Verheugt FW
    Clin Gastroenterol Hepatol; 2008 Mar; 6(3):309-13. PubMed ID: 18242146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and independent factors for gastroduodenal ulcers/erosions in asymptomatic patients taking low-dose aspirin and gastroprotective agents: the OITA-GF study.
    Tamura A; Murakami K; Kadota J;
    QJM; 2011 Feb; 104(2):133-9. PubMed ID: 20870780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of aspirin--and NSAID-induced peptic ulcers].
    Satoh K; Tanabe H; Ichiishi E; Ando K
    Nihon Rinsho; 2015 Jul; 73(7):1110-5. PubMed ID: 26165066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The present state and problem of gastric ulcer caused by low-dose aspirin].
    Hirasawa T; Satoh K; Sugano K
    Nihon Rinsho; 2010 Nov; 68(11):1983-6. PubMed ID: 21061520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of H. pylori infection on upper gastrointestinal damage].
    Kawai T; Fukuzawa M; Moriyasu F; Yamashina A
    Nihon Rinsho; 2010 Nov; 68(11):2020-4. PubMed ID: 21061526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of low-dose aspirin on the decreased risk of development of dyspepsia and gastrointestinal ulcers associated to cyclooxygenase-2 selective inhibitors.
    Benito-Garcia E; Michaud K; Wolfe F
    J Rheumatol; 2007 Aug; 34(8):1765-9. PubMed ID: 17611980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
    Taha AS; McCloskey C; Prasad R; Bezlyak V
    Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible low-dose-aspirin-induced gastropathy.
    Baker PN; Williamson JG; Louden KA
    Lancet; 1992 Feb; 339(8792):550. PubMed ID: 1346892
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic arthritis research and gastrointestinal event trial of lumiracoxib - study design and patient demographics.
    Hawkey CJ; Farkouh M; Gitton X; Ehrsam E; Huels J; Richardson P
    Aliment Pharmacol Ther; 2004 Jul; 20(1):51-63. PubMed ID: 15225171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low-dose aspirin.
    Takeuchi T; Ota K; Harada S; Kojima Y; Inoue T; Iwakiri R; Sakata Y; Fujimoto K; Fujita T; Azuma T; Higuchi K
    J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():11-5. PubMed ID: 25521726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori and low-dose aspirin ulcer risk: A meta-analysis.
    Sarri GL; Grigg SE; Yeomans ND
    J Gastroenterol Hepatol; 2019 Mar; 34(3):517-525. PubMed ID: 30408229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing the gastrointestinal risks of low-dose aspirin.
    Cryer B
    Gastroenterology; 2010 Jan; 138(1):30-3. PubMed ID: 19932668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.